Gene expression profile of DNA binding protein A transgenic mice

International Journal of Oncology

Volumn 29, Issue 3, 2006, Pages 673-679

  Tobita, Hiroshi ^a,b   Kajino, Kazunori ^a   Inami, Kouichi ^a   Kano, Sayaka ^a   Yasen, Mahmut ^a   Imamura, Osamu ^a   Kinoshita, Yoshikazu ^b   Hino, Okio ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

dbpA; Hepatocarcinogenesis; Microarray analysis; siRNA; Transgenic mouse

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CSDA PROTEIN, HUMAN; HEAT SHOCK PROTEIN; TRANSCRIPTION FACTOR; TUMOR MARKER;

ANIMAL; ARTICLE; C57BL MOUSE; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LIVER; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; MOUSE; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CCAAT-ENHANCER-BINDING PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAT-SHOCK PROTEINS; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TRANSGENES; TUMOR MARKERS, BIOLOGICAL;

EID: 33749325789     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.29.3.673     Document Type: Article

References (37)

1. Mahmut Y, Kajino K, Kano S, et al: The up-regulation of Y-box binding proteins (DNA binding protein A and Y-box binding protein-1) as prognostic marker of hepatocellular carcinoma. Clin Cancer Res 11: 7354-7361, 2005.
2. Arakawa Y, Kajino K, Kano S, et al: Transcription of dbpA, a Y box binding protein, is positively regulated by E2F1: implications in hepatocarcinogenesis. Biochem Biophys Res Commun 322: 297-302, 2004.
3. Conner EA, Lammer ER, Omori M, et al: Dual functions of E2F1 in a transgenic mouse model of liver carcinogenesis. Oncogene 19: 5054-5062, 2000.
4. Bargou RC, Jurchott K, Wagener C, et al: Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nat Med 3: 447-450, 2001.
5. Kamura T, Yahata H, Amada S, et al: Is nuclear expression of Y box-binding protein-1 a new prognostic factor in ovarian serous adenocarcinoma? Cancer 85: 2450-2454, 1999.
6. Shibahara K, Sugio K, Osaki T, et al: Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer. Clin Cancer Res 7: 3151-3155, 2001.
7. Ito Y, Yoshida H, Shibahara K, et al: Y-box binding protein expression in thyroid neoplasms: its linkage with anaplastic transformation. Pathol Int 53: 429-433, 2003.
8. Oda Y, Ohishi Y, Saito T, et al: Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase IIα expression, and with poor prognosis in synovial sarcoma. J Pathol 199: 251-258, 2003. (Pubitemid 36176032)
9. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987. (Pubitemid 17064313)
10. Toyonaga T, Hino O, Sugai S, et al: Chronic active hepatitis in transgenic mice expressing interferon-γ in the liver. Proc Natl Acad Sci USA 91: 614-618, 1994. (Pubitemid 24041452)
11. Stephan B, Brigitte R-P, Ellen F, et al: YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification. Cancer Res 65: 4078-4087, 2005.
12. Taub R: Liver regeneration 4: transcriptional control of liver regeneration. FASEB J 10: 413-427, 1996.
13. Kondoh N, Wakatsuki T, Ryo A, et al: Identification and characterization of genes associated with human hepatocellular carcinogenesis. Cancer Res 59: 4990-4996, 1999. (Pubitemid 29472905)
14. Maione D, Di Carlo E, Li W, et al: Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver. EMBO J 17: 5588-5597, 1998. (Pubitemid 28445970)
15. Leu JI, Crissey MA, Craig LE and Taub R: Impaired hepatocyte DNA synthetic response posthepatectomy in insulin-like growth factor binding protein 1-deficient mice with defects in C/EBP beta and mitogen-activated protein kinase/extracellular signal-regulated kinase regulation. Mol Cell Biol 23: 1251-1259, 2003.
16. Hanby AM, McKee P, Jeffery M, et al: Primary musinous carcinomas of the skin express TFF1, TFF3, estrogen receptor and progesterone receptors. Am J Surg Pathol 22: 1125-1131, 1998. (Pubitemid 28411071)
17. Taupin D, Ooi K, Yeomans N and Giraud A: Conserved expression of intestinal trefoil factor in the human colonic adenoma-carcinoma sequence. Lab Invest 75: 25-32, 1996. (Pubitemid 26250270)
18. May FE and Westley BR: Expression of human intestinal trefoil factor in malignant cells and its regulation by oestrogen in breast cancer cells. J Pathol 182: 404-413, 1997.
19. Faith DA, Isaacs WB, Morgan JD, et al: Trefoil factor 3 overexpression in prostatic carcinoma: prognostic importance using tissue microarrays. Prostate 61: 215-227, 2004.
20. Khoury T, Chadha K, Javle M, et al: Expression of intestinal trefoil factor (TFF-3) in hepatocellular carcinoma. Int J Gastrointest Cancer 35: 171-178, 2005. (Pubitemid 41176330)
21. Yio X, Zhang JY, Babyatsky M, et al: Trefoil factor family-3 is associated with aggressive behavior of colon cancer cells. Clin Exp Metastasis 22: 157-165, 2005. (Pubitemid 41185853)
22. Rivat C, Rodrigues S, Bruyneel E, et al: Implication of STAT3 signaling in human colonic cancer cells during intestinal trefoil factor 3 (TFF3) and vascular endothelial growth factor-mediated cellular invasion and tumor growth. Cancer Res 65: 195-202, 2005.
23. Okada H, Kimura MT, Tan D, et al: Frequent trefoil factor 3 (TFF3) overexpression and promoter hypomethylation in mouse and human hepatocellular carcinomas. Int J Oncol 26: 369-377, 2005.
24. Graveel CR, Jatkoe T, Madore SJ, et al: Expression profiling and identification of novel genes in hepatocellular carcinomas. Oncogene 20: 2704-2712, 2001. (Pubitemid 32525301)
25. Darabi A, Gross S, Watabe M, Maiafa M and Watabe K: Differential gene expression in experimental hepatocellular carcinoma induced by woodchuck hepatitis B virus. Cancer Lett 95: 153-159, 1995.
26. Fallet E, Pirisi M, Fabris C, et al: Increase of serum alpha 1-acid glycoprotein despite the decline of liver synthetic function in cirrhotics with hepatocellular carcinoma. Eur J Clin Chem Clin Biochem 31: 407-411, 1993. (Pubitemid 23241877)
27. Leto G, Tumminello FM, Pizzolanti G, et al: Lysosomal cathepsins B and L and Stefin A blood levels in patients with hepatocellular carcinoma and/or liver cirrhosis: potential clinical implications. Oncology 57: 79-83, 1997. (Pubitemid 26413324)
28. Palumbo JS, Talmage KE, Liu H, La Jeunesse CM, Witte DP and Degen JL: Plasminogen supports tumor growth through a fibrinogen-dependent mechanism linked to vascular patency. Blood 102: 2819-2827, 2003. (Pubitemid 37248852)
29. Bezerra JA, Bugge TH, Melin-Aldana H and Sabla G: Plasminogen deficiency leads to impaired remodeling after a toxic injury to the liver. Proc Natl Acad Sci USA 96: 15143-15148, 1999. (Pubitemid 30019779)
30. Bezerra JA, Currier AR, Melin-Aldana H and Sabla G: Plasminogen activators direct regeneration of the liver lobule after acute injury. Am J Pathol 158: 921-929, 2001. (Pubitemid 32221784)
31. Ng VL, Sabla GE, Melin-Aldana H and Kelley-Loughane: Plasminogen deficiency results in poor clearance of non-fibrin matrix and persistent activation of hepatic stellate cells after an acute injury. J Hepatol 35: 781-789, 2001. (Pubitemid 34717670)
32. Pohl JF, Melin-Aldana H, Sabla G, Degen JL and Bezerra JA: Plasminogen deficiency leads to impaired lobular reorganization and matrix accumulation after chronic liver injury. Am J Pathol 159: 2179-2186, 2001. (Pubitemid 33104272)
33. Sullivan CS and Pipas JM: T antigens of simian virus 40: molecular chaperones for viral replication and tumorigenesis. Microbiol Mol Biol Rev 66: 179-202, 2002. (Pubitemid 34625707)
34. Lii CK, Chai YC, Zhao W, Thomas JA and Hendrich S: S-thiolation and irreversible oxidation of sulfhydryls on carbonic anhydrase III during oxidative stress: a method for studying protein modification in intact cells and tissues. Arch Biochem Biophys 308: 231-239, 1994. (Pubitemid 24172628)
35. Raisanen SR, Lehenkari P, Tasanen M, Rahkila P, et al: Carbonic anhydrase III protects cells from hydrogen peroxide-induced apoptosis. FASEB J 13: 513-522, 1999. (Pubitemid 29115569)
36. Kuo WH, Chiang WL, Yang SF, Yeh KT, et al: The differential expression of cytosolic carbonic anhydrase in human hepatocellular carcinoma. Life Sci 73: 2211-2223, 2003. (Pubitemid 36962969)
37. Elchuri S, Oberley TD, Qi W, Eisenstein RS, et al: CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene 24: 367-380, 2005. (Pubitemid 40188585)